The subject matter herein generally relates to a contact lens and a method for making the contact lens.
Colored contact lenses are commonly worn by users to correct vision, or for cosmetic or therapeutic reasons. A colored contact lens usually comprises a substrate and a colored ink film formed on the substrate. However, forming the colored ink film on the substrate may be complicated and costly.
Implementations of the present technology will now be described, by way of example only, with reference to the attached figures.
It will be appreciated that for simplicity and clarity of illustration, where appropriate, reference numerals have been repeated among the different figures to indicate corresponding or analogous elements. In addition, numerous specific details are set forth in order to provide a thorough understanding of the embodiments described herein. However, it will be understood by those of ordinary skill in the art that the embodiments described herein can be practiced without these specific details. In other instances, methods, procedures, and components have not been described in detail so as not to obscure the related relevant feature being described. Also, the description is not to be considered as limiting the scope of the embodiments described herein. The drawings are not necessarily to scale and the proportions of certain parts may be exaggerated to better illustrate details and features of the present disclosure.
The term “substantially” is defined to be essentially conforming to the particular dimension, shape or other word that substantially modifies, such that the component need not be exact. For example, substantially cylindrical means that the object resembles a cylinder, but can have one or more deviations from a true cylinder. The term “comprising” when utilized, means “including, but not necessarily limited to”; it specifically indicates open-ended inclusion or membership in the so-described combination, group, series and the like.
At block 201, referring to
The female die 31 comprises a first surface 310 and a second surface 311 facing away from the first surface 310. A cavity 313 is defined at the first surface 310. The male die 33 comprises a third surface 330 and a fourth surface 331 facing away from the third surface 330. A mold core 333 protrudes from the third surface 330. The mold core 333 matches the cavity 313. The mold 3 is made of a material which the ultraviolet radiation can pass through.
At block 202, a mixture is injected into the cavity 313, and then the male die 33 is covered on the female die 31. The mixture comprises a photosensitive solution and a gel precursor. The photosensitive solution and the gel precursor are in a ratio of about 2:3 to about 4:1 by volume.
The photosensitive solution comprises deionized water, potassium ferricyanide, and ammonium ferric citrate. The potassium ferricyanide and the ammonium ferric citrate are dissolved in the deionized water. The potassium ferricyanide and the ammonium ferric citrate are in a ratio of 1:1 by weight.
The gel precursor comprises hydrophilic monomers, a cross-linking agent, and an initiator. In at least one exemplary embodiment, the hydrophilic monomers have a mass percentage of about 40% to about 98% of a total mass of the gel precursor. The cross-linking agent has a mass percentage of about 0.1% to about 15% of a total mass of the gel precursor. The initiator has a mass percentage of about 0.05% to about 46% of a total mass of the gel precursor.
The hydrophilic monomers may be selected from a group consisting of methacryloxyalkylsiloxanes, 3-methacryloxypropylpentamethyldisiloxane, bis(methacryloxypropyl)tetramethyl-disiloxane, monomethacrylatedpolydimethylsiloxane, mercapto-terminatedpolydimethylsiloxane, N-[tris(trimethylsiloxy)silylpropyl]acrylamide, N-[tris(trimethylsiloxy)silylpropyl]methacrylamide, tris(pentamethyldisiloxyanyl)-3-methacrylatopropylsilane (T2), 3-methacryloxypropyletris(trimethylsiloxy)silane, 2-hydroxyethylmethacrylate (HEMA), hydroxyethyl acrylate, hydroxypropyl acrylate, hydroxypropyl methacrylate (HPMA), trimethylammonium 2-hydroxy propylmethacrylate hydrochloride, dimethylaminoethyl methacrylate (DMAEMA), dimethylaminoethylmethacrylamide, acrylamide, methacrylamide, allyl alcohol, vinylpyridine, glycerol methacrylate, N-(1,1dimethyl-3-oxobutyl)acrylamide, N-vinyl-2-pyrrolidone (NVP), acrylic acid, methacrylic acid, and N,N-dimethyacrylamide (DMA).
The cross-linking agent may be selected from a group consisting of ethylene glycol dimethacrylate (EGDMA), trimethylolpropane trimethacrylate (TMPTMA), tri(ethylene glycol) dimethacrylate (TEGDMA), tri(ethylene glycol) divinyl ether (TEGDVE), and trimethylene glycol dimethacrylate.
The initiator may be a photoinitiator or a thermal initiator.
The photoinitiator may be selected from a group consisting of benzoin methyl ether, diethoxyacetophenone, a benzoylphosphine oxide initiator, ethyl 2-dimethylaminobenzoate, 2-isopropylthioxanthone, 1-hydroxycyclohexyl phenyl ketone, Darocur type initiator and Irgacur type initiator. The photoinitiator can absorb ultraviolet light having a first wavelength. The photosensitive solution can absorb ultraviolet light having a second wavelength. The first wavelength is different from the second wavelength. In at least one exemplary embodiment, the photoinitiator may be Irgacure-819. The benzoylphosphine oxide initiator may be selected from a group consisting of 2,4,6-trimethylbenzoyldiphenylophosphine oxide, bis-(2,6-dichlorobenzoyl)-4-N-propylphenylphosphine oxide, and bis-(2,6-dichlorobenzoyl)-4-N-butylphenylphosphine oxide.
The thermal initiator may be selected from a group consisting of 2,2′-azobis (2,4-dimethylpentanenitrile), 2,2′-azobis (2-methylpropanenitrile), 2,2′-azobis (2-methylbutanenitrile), azobisisobutyronite (AIBN), and peroxide. The peroxide can be benzoyl peroxide.
At block 203, referring to
In at least one exemplary embodiment, the hollow pattern 40 is substantially annular. In another exemplary embodiment, the shape of the hollow pattern 40 may be varied. For example, the hollow pattern 40 may comprise a plurality of concentric rings.
At block 204, the mold 3 is heated, or a portion of the mold 3 without the covering film 4 is exposed to ultraviolet light having the first wavelength, to cause the gel precursor to undergo a polymerization reaction to form a gel. Furthermore, the covering film 4 is exposed to ultraviolet light having the second wavelength, to cause a portion of the photosensitive solution corresponding to the hollow pattern 40 to generate prussian blue pigments 15. The prussian blue pigments 15 are dispersed in the gel to cause a portion of the gel corresponding to the hollow pattern 40 to show blue color.
In at least one exemplary embodiment, the mold 3 is heated or exposed to the ultraviolet light having the first wavelength for about 0.5 min to about 60 min. The covering film 4 is exposed to the ultraviolet light having the second wavelength for about 0.1 min to about 10 min. The second wavelength is about 355 nm to about 375 nm. A temperature for heating is from about 50 degree centigrade to about 90 degree centigrade.
At block 205, the gel with the prussian blue pigments 15 is separated from the mold 3, and is cleaned to remove any unreacted photosensitive solution, thereby forming the contact lens 1.
In another exemplary embodiment, the photosensitive solution comprises deionized water, silver nitrate, and sodium chloride. The silver nitrate and the sodium chloride are in a ratio of 1:1 by weight. When the covering film 4 is exposed to a light having the second wavelength, to cause a portion of the photosensitive solution corresponding to the hollow pattern 40 to generate silver chloride pigments 15. The second wavelength is about 500 nm to about 560 nm.
It is to be understood, even though information and advantages of the present embodiments have been set forth in the foregoing description, together with details of the structures and functions of the present embodiments, the disclosure is illustrative only; changes may be made in detail, especially in matters of shape, size, and arrangement of parts within the principles of the present embodiments to the full extent indicated by the plain meaning of the terms in which the appended claims are expressed.
Number | Date | Country | Kind |
---|---|---|---|
106106686 | Mar 2017 | TW | national |